Abstract
BackgroundWith the successful development of modern immunotherapy, immune checkpoint inhibitors (ICIs) are currently considered potential therapeutic options for patients with cancer. However, the therapeutic potential of ICIs in human cancer...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have